TABLETTEN MIT ELTROMBOPAG OLAMIN

European patent · EP4400104 · In force

Register entry

Publication number
EP4400104
Application number
EP24178734
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Aug 1, 2007
Published
Jul 17, 2024
Granted
Apr 22, 2026
Protection ends at the latest
Jul 31, 2027
Next annual fee due
Aug 31, 2027
IPC classes
A61K 9/14 (2006.01)
A61K 9/54 (2006.01)
A61K 47/34 (2017.01)
A61P 7/06 (2006.01)
A61K 31/4152 (2006.01)
A61K 9/20 (2006.01)
A61K 47/26 (2006.01)
Priority
US 915761 P 03.05.2007
US 947731 P 03.07.2007
Divided from
EP23166857
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 1, 2026

    Next annual fee due on

    Next annual fee due on
    31.08.2026 → 31.08.2027

    Published in Swissreg on 01.09.2026

  2. Apr 22, 2026

    Granted

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 22.04.2026

Parties

Holder

Novartis Pharma AG

Lichtstrasse 35, 4056 Basel

Inventor

KAPSI, Shivakumar, G.

King Of Prussia, 19406, US

MULLER, Francis, X.

King Of Prussia, 19406, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.